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Sanjay Rajagopalan, MD,a Taehoon Shin, PHDb“Begin, be bold, and venture to be wise.”
— Horace (1)T he management of peripheral arterial disease(PAD) still heavily relies on clinical judgmentand the use of the ankle-brachial pressure in-
dex (ABPI), originally described in 1950 for the noninva-
sive diagnosis of lower extremity arterial disease (2).
With the exception of technical improvements in the
angiographic detection of macrovascular disease using
magnetic resonance (MRI) and computed tomographic
imaging, we are not “wiser” with regard to obtaining a
metric of tissue level perfusion. Tissue oxygenation
is, after all, the ultimate gold standard that may allow
better discrimination of what the end organ is experi-
encing and facilitate clinical decision making.
Although multiple modalities have been pro-
claimed as able to provide such information, clinically
embracing such modalities has been challenged by
poor precision, poor reproducibility, and superﬁcial
resolution (3). The use of MRI methodologies to
determine tissue level oxygenation information is not
new, but rather dates back to the early 1990s when
Ogawa et al. (4) ﬁrst utilized blood oxygenation
leveldependent (BOLD) contrast as a “functional”
mapping technique to determine improvement in
blood ﬂow and oxygenation to mental processes. The
BOLD technique measures inhomogeneities in the
magnetic ﬁeld due to changes in the level of oxygen.
Oxygenated blood is diamagnetic whereas deoxy-
genated blood is paramagnetic. Thus, a high ratio of
deoxygenated/oxygenated blood results in micro-
scopic ﬁeld inhomogeneity and a subsequent loss in*Editorials published in the Journal of the American College of Cardiology
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performed in 1998 to study tissue oxygenation in the
lower extremities, the ﬁrst use of BOLD in PAD was
not reported until 2006 (5,6).
While appealing as a clinically relevant index, the
use of BOLD in PAD has remained in the research
domain for multiple reasons. Of foremost importance
is that the lower extremity poses challenges in terms of
generating adequate BOLD signal. Although total
perfusion at rest to the skeletal muscle in healthy
adults is large, accounting for up to 17% of the cardiac
output (900 ml/min), the perfusion rate averaged over
the entire organ is a mere 3 ml/100 g/min. This
contrasts with the brain and the liver, which receive
56 ml/100 g/min and 100 ml/100 g/min, respectively
(7). Augmentation of ﬂow in response to a provocative
stimulus is often leveraged as a tool to exaggerate
perfusion (8). The increase in perfusion with exercise
or pharmacological vasodilation is dramatic in the
skeletal muscle, with a 20-fold to 40-fold increase in
ﬂow. Still, the relative increase in signal intensity seen
with BOLD in the extremity is modest at best (8).
In critical limb ischemia (CLI) there are multiple
additional challenges for BOLD imaging. First, there is
limitation not only in resting ﬂow but also in
recruitable ﬂow due to a maximally dilated, anatom-
ically restricted arterial bed owing to extensive
multilevel, multisegment disease. This precludes
delivery of an adequate “pressure head” of hemo-
globin to generate signal. Further, long contact time
between the blood, myoglobin, and oxygen-
consuming myocytes occurs, resulting in efﬁcient
deoxygenation of oxyhemoglobin and a higher ﬁnal
concentration of deoxyhemoglobin, contributing to
an overall reduction in peak signal and the method’s
dynamic range. Second, the multiple parameters
require laborious manual analysis, which may be
clinically impractical. Third, prior studies have sug-
gested that measures such as time-to-peak and T2*
maximum may not be easily identiﬁable or repro-
ducible with a coefﬁcient of variation of up to 51% (9).
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433Finally, related to all of the above factors, discrimi-
nation of 1 PAD patient from the other, or assessment
of small changes, may not always be possible.SEE PAGE 420The work by Bajwa et al. (10) in this issue of the
Journal represents an improvement over prior BOLD
approaches and ventures to be “wiser” in approaching
tissue oxygenation in CLI. The authors should be
congratulated for incorporating technical improve-
ments including use of 3-T, higher spatial resolution
(allowing for accurate region-of-interest placement,
avoiding blood vessels that may contaminate T2*
values), and use of a larger number of echo times (14 vs.
3 to 4), allowing for accurate delineation of T2* decay.
Traditional parameters such as time-to-peak (with
reactive hyperemia), time-to-half ischemia, and
maximum T2* were examined in addition to other
semi-automated measures, such as gradient of rise of
T2* signal (Grad) and changes in T2* signal during
ischemia (signal reduction during ischemia). Addi-
tional strengths include testing of reproducibility and
validation with histological measures of capillary
density (capillary/ﬁber ratio and CD31 staining).
The main ﬁndings were the demonstration of
feasibility and reproducibility of BOLD. Importantly,
the measures improved with revascularization given
additional differential improvement in BOLD indexes
(but not ABPI) between patients who differed in the
patency status of the superﬁcial femoral artery.
Superﬁcial femoral artery and profunda femoris
patency are well-known determinants of limb salvage
and outcomes in patients with CLI (11). BOLD mea-
surements could still be obtained in patients in
whom ABPI measurements were unobtainable (5 of
13 patients) owing to calciﬁed arteries. The authors
obtained muscle biopsy specimens and demonstrated
reduced capillary ﬁber ratio in the ischemic area at
the level of BOLD imaging. Capillary ﬁber ratio was
reduced at the BOLD level compared to better-
perfused proximal zones. (BOLD perfusion was not
performed proximally).
This study’s clinical relevance lies in the fact that
an objective measure of perfusion may facilitate de-
cision making. Although BOLD has been previouslyused in patients with intermittent claudication, the
poor signal-to-noise ratio (SNR) and lack of dynamic
range have been major limitations (6). The use of the
technique in CLI and discriminate response following
revascularization are major strengths of this paper.
There were weaknesses, too, including the inability to
discriminate between those with or without diabetes
and smokers from nonsmokers and the fact that a
subset of patients may not be able to be imaged (those
who cannot lie still due to rest pain or those with
extensive tissue damage or recent surgery).
How does this method compare to other MRI ap-
proaches such as dynamic contrast enhancement and
arterial spin labeling (ASL) that provide information
on tissue-level perfusion? The compelling advantage
of dynamic contrast enhancement is superior SNR,
owing to the use of gadolinium-based contrast
agents. However, gadolinium administration may be
an issue in patients with CLI, many of whom have
chronic kidney disease. Moreover, for absolute
quantiﬁcation of perfusion, knowledge of the con-
centration of contrast in the blood plasma is required
but may be difﬁcult to obtain in CLI patients who
often lack discernible vessels below the knee. ASL
uses magnetically “labeled” arterial blood as an
endogenous tracer and measures the delivery of the
labeled blood into tissue, allowing for perfusion
quantiﬁcation in absolute units (12). As in BOLD, low
SNR is the main drawback of ASL and may render the
evaluation of CLI patients difﬁcult, although prom-
ising results have been obtained in patients with
intermittent claudication (13).
Ultimately, the availability of noninvasive ap-
proaches that provide insights into tissue perfusion
and response to therapeutic intervention may rein-
vigorate interest in new therapeutic modalities.
However, we may ﬁrst need to be bold in CLI, by
exploring new approaches that may ultimately lead to
wisdom.
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